15555

539787

HCG

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

HEALTHCARE GLOB. ENT. LTD Share Price Update

As of the latest trading session, HEALTHCARE GLOB. ENT. LTD is trading at ₹629.15, down by ₹-2.50 or -0.39% from its previous close. The stock has moved between ₹625.00 and ₹635.35 today. Over the past year, the stock has delivered a return of 18.42%. In the last month, it has returned 6.65%.

HEALTHCARE GLOB. ENT. LTD performance

Today’s low Today’s high
₹ 625.00 ₹ 635.35
₹ 629.40
52 week low 52 week high
₹ 513.30 ₹ 799.71
₹ 629.40
Open Price ₹ 632.05
Prev. Close ₹ 631.65
Volume (Shares) 42905.00
Total traded value ₹ 270.04
Upper Circuit ₹ 757.95
Lower Circuit ₹ 505.35
info

Investment Returns

Over 1 Month 6.65% Over 3 Months 15.39% Over 6 Months -12.02% Over 1 Year 18.42%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

HEALTHCARE GLOB. ENT. LTD fundamentals


  • Market cap (Cr) 9,392.60
  • P/E Ratio (TTM) 644.95
  • Beta 0.75
  • Book Value / share 107.48
  • Return on equity 0.12%
  • EPS (TTM) 4.42
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 1.53
info icon alternate text
  • Market cap (Cr) 9,391.10
  • P/E Ratio (TTM) 644.95
  • Beta 0.67
  • Book Value / share 107.48
  • Return on equity 0.12%
  • EPS (TTM) 4.42
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 1.53
info icon alternate text

HEALTHCARE GLOB. ENT. LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 348.47
Operating Expense 326.56
Net Profit 1.53
Net Profit Margin (%) 0.43
Earnings Per Share (EPS) 0.11
EBITDA 42.54
Effective Tax Rate (%) 117.09
Particulars DEC 2025 (Values in Cr)
Revenue 340.56
Operating Expense 338.56
Net Profit -1.18
Net Profit Margin (%) -0.34
Earnings Per Share (EPS) -0.08
EBITDA 49.43
Effective Tax Rate (%) 7.08
Particulars SEP 2025 (Values in Cr)
Revenue 344.41
Operating Expense 335.06
Net Profit 10.78
Net Profit Margin (%) 3.12
Earnings Per Share (EPS) 0.77
EBITDA 66.12
Effective Tax Rate (%) 26.16
Particulars JUN 2025 (Values in Cr)
Revenue 325.93
Operating Expense 329.79
Net Profit 3.45
Net Profit Margin (%) 1.05
Earnings Per Share (EPS) 0.25
EBITDA 57.79
Effective Tax Rate (%) 34.16
Particulars MAR 2025 (Values in Cr)
Revenue 322.80
Operating Expense 317.04
Net Profit 10.15
Net Profit Margin (%) 3.14
Earnings Per Share (EPS) 0.73
EBITDA 68.35
Effective Tax Rate (%) 39.58
Particulars MAR 2026 (Values in Cr)
Revenue 1359.37
Operating Expense 1329.97
Net Profit 14.58
Net Profit Margin (%) 1.07
Earnings Per Share (EPS) 1.03
EBITDA 215.88
Effective Tax Rate (%) -51.55
Particulars MAR 2025 (Values in Cr)
Revenue 1276.52
Operating Expense 1260.70
Net Profit 3.53
Net Profit Margin (%) 0.27
Earnings Per Share (EPS) 0.25
EBITDA 215.11
Effective Tax Rate (%) 81.97
Particulars MAR 2024 (Values in Cr)
Revenue 1170.66
Operating Expense 1117.06
Net Profit 32.80
Net Profit Margin (%) 2.80
Earnings Per Share (EPS) 2.36
EBITDA 200.69
Effective Tax Rate (%) 38.91
Particulars MAR 2023 (Values in Cr)
Revenue 1005.57
Operating Expense 955.77
Net Profit 40.19
Net Profit Margin (%) 3.99
Earnings Per Share (EPS) 2.89
EBITDA 188.07
Effective Tax Rate (%) 30.24
Particulars MAR 2022 (Values in Cr)
Revenue 849.83
Operating Expense 834.12
Net Profit 38.25
Net Profit Margin (%) 4.50
Earnings Per Share (EPS) 2.95
EBITDA 212.20
Effective Tax Rate (%) 52.80
Particulars MAR 2025 (Values in Cr)
Book Value / Share 66.16
ROE % 3.68
ROCE % 7.13
Total Debt to Total Equity 1.78
EBITDA Margin 19.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share 59.28
ROE % 3.14
ROCE % 7.19
Total Debt to Total Equity 1.29
EBITDA Margin 18.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 61.86
ROE % 1.35
ROCE % 6.56
Total Debt to Total Equity 1.05
EBITDA Margin 18.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 62.61
ROE % -0.62
ROCE % 4.62
Total Debt to Total Equity 1.21
EBITDA Margin 17.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 52.11
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.16
EBITDA Margin 14.19
Particulars MAR 2025 (Values in Cr)
Book Value / Share 85.45
ROE % 0.12
ROCE % 6.00
Total Debt to Total Equity 0.79
EBITDA Margin 19.58
Particulars MAR 2024 (Values in Cr)
Book Value / Share 84.82
ROE % 3.12
ROCE % 6.25
Total Debt to Total Equity 0.48
EBITDA Margin 18.49
Particulars MAR 2023 (Values in Cr)
Book Value / Share 82.31
ROE % 3.07
ROCE % 5.85
Total Debt to Total Equity 0.31
EBITDA Margin 18.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share 78.96
ROE % 1.19
ROCE % 4.55
Total Debt to Total Equity 0.41
EBITDA Margin 18.75
Particulars MAR 2021 (Values in Cr)
Book Value / Share 70.19
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.85
EBITDA Margin 16.02
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 347.69
Total Assets 3543.23
Total Liabilities 3543.23
Total Equity 990.04
Share Outstanding 13
Price to Book Ratio 6.30
Return on Assets (%) 1.25
Return on Capital (%) 2.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 303.07
Total Assets 2707.49
Total Liabilities 2707.49
Total Equity 865.11
Share Outstanding 13
Price to Book Ratio 3.99
Return on Assets (%) 1.77
Return on Capital (%) 3.13
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 196.63
Total Assets 2316.01
Total Liabilities 2316.01
Total Equity 869.41
Share Outstanding 13
Price to Book Ratio 3.19
Return on Assets (%) 1.26
Return on Capital (%) 2.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 197.50
Total Assets 2219.52
Total Liabilities 2219.52
Total Equity 883.71
Share Outstanding 13
Price to Book Ratio 3.42
Return on Assets (%) 2.42
Return on Capital (%) 4.16
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 40.85
Total Assets 2035.61
Total Liabilities 2035.61
Total Equity 714.00
Share Outstanding 12
Price to Book Ratio 2.72
Return on Assets (%) -9.50
Return on Capital (%) -16.32
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 264.14
Total Assets 2603.79
Total Liabilities 2603.79
Total Equity 1191.32
Share Outstanding 13
Price to Book Ratio 6.30
Return on Assets (%) 0.13
Return on Capital (%) 0.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 237.33
Total Assets 2187.89
Total Liabilities 2187.89
Total Equity 1188.58
Share Outstanding 13
Price to Book Ratio 3.99
Return on Assets (%) 1.55
Return on Capital (%) 2.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 80.36
Total Assets 1729.70
Total Liabilities 1729.70
Total Equity 1145.12
Share Outstanding 13
Price to Book Ratio 3.19
Return on Assets (%) 2.32
Return on Capital (%) 3.17
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 119.95
Total Assets 1643.61
Total Liabilities 1643.61
Total Equity 1097.69
Share Outstanding 13
Price to Book Ratio 3.42
Return on Assets (%) 2.32
Return on Capital (%) 3.17
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 14.46
Total Assets 1574.51
Total Liabilities 1574.51
Total Equity 923.78
Share Outstanding 12
Price to Book Ratio 2.72
Return on Assets (%) -12.16
Return on Capital (%) -16.47
Particulars MAR 2025 (Values in Cr)
Net Income 56.96
Cash from Operations 348.99
Cash from Investing -487.75
Cash from Financing -42.43
Net change in Cash -213.08
Free Cash Flow 557.85
Particulars MAR 2024 (Values in Cr)
Net Income 67.72
Cash from Operations 331.94
Cash from Investing -225.72
Cash from Financing -64.01
Net change in Cash -5.16
Free Cash Flow 517.62
Particulars MAR 2023 (Values in Cr)
Net Income 44.88
Cash from Operations 274.30
Cash from Investing -133.03
Cash from Financing -140.06
Net change in Cash -21.50
Free Cash Flow 407.54
Particulars MAR 2022 (Values in Cr)
Net Income 87.77
Cash from Operations 243.82
Cash from Investing 124.58
Cash from Financing -154.88
Net change in Cash 189.82
Free Cash Flow 315.05
Particulars MAR 2021 (Values in Cr)
Net Income -228.66
Cash from Operations 82.55
Cash from Investing -171.10
Cash from Financing 112.24
Net change in Cash 61.65
Free Cash Flow 117.97
Particulars MAR 2025 (Values in Cr)
Net Income 19.58
Cash from Operations 164.50
Cash from Investing -347.32
Cash from Financing -41.55
Net change in Cash -242.92
Free Cash Flow 297.22
Particulars MAR 2024 (Values in Cr)
Net Income 53.70
Cash from Operations 242.00
Cash from Investing -253.93
Cash from Financing 95.91
Net change in Cash 50.87
Free Cash Flow 371.20
Particulars MAR 2023 (Values in Cr)
Net Income 57.62
Cash from Operations 147.64
Cash from Investing -137.70
Cash from Financing -41.71
Net change in Cash -49.02
Free Cash Flow 249.76
Particulars MAR 2022 (Values in Cr)
Net Income 81.04
Cash from Operations 139.11
Cash from Investing 48.64
Cash from Financing -41.04
Net change in Cash 132.00
Free Cash Flow 181.56
Particulars MAR 2021 (Values in Cr)
Net Income -205.05
Cash from Operations 30.45
Cash from Investing -245.62
Cash from Financing 235.92
Net change in Cash 61.18
Free Cash Flow 53.38
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8099.40 59.53 12.29 116456.95 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 53.36 24.14 2.91 100.01 40.75 77.00
SHREE PACETRONIX LTD. 130.75 15.60 2.75 49.03 66.10 283.15
TRANSGENE BIOTEK LTD. 3.10 0.00 2.80 23.49 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8099.40 77.57 11.68 116456.95 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.30 0.00 -9.56 29.36 30.30 57.48
KOVAI MEDICAL CENTER & HOSPITA 5372.55 24.04 4.45 5877.57 5010.00 6725.00

HEALTHCARE GLOB. ENT. LTD shareholding pattern

Holding
14.13%
64.2%
2.75%
18.9%
5.17%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

HEALTHCARE GLOB. ENT. LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
629.10 -0.40 redarrow
red-green-graph indicator
9 Bearish
7 Bullish
  • 5 Days 642.10
  • 26 Days 622.40
  • 10 Days 640.90
  • 50 Days 606.70
  • 12 Days 639.00
  • 100 Days 606.50
  • 20 Days 629.30
  • 200 Days 605.70
642.22 PIVOT
First Support 635.18 First Resistance 653.18 Second Support 624.22 Second Resistance 660.22 Third Support 617.18 Third Resistance 671.18
RSI 59.26 ADX 30.29 MACD 18.75 Williams % R -25.52 Commodity Channel Index (CCI) 49.45
Date 2026-06-01 Week 121303.00 Same Day 34988.00 Month 122768.00
1 Year 0.76 3 Year 0.59
Over 1 Month
6.65% down
Over 1 Year
18.42% down
Over 3 Months
15.39% down
Over 3 Years
26.60% down
Over 6 Months
-12.02% down
Over 5 Years
29.03% down

HEALTHCARE GLOB. ENT. LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Healthcare Global Enterprises Ltd?

Answer Field

Healthcare Global Enterprises Ltd share price is for NSE ₹ 629.15 & for BSE ₹ 629.90 as on Jun 03 2026 12:46 PM.

What is the Market Cap of Healthcare Global Enterprises Ltd Share?

Answer Field

The market cap of Healthcare Global Enterprises Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 03 2026 12:46 PM.

What is the 52 Week High and Low of Healthcare Global Enterprises Ltd?

Answer Field

The 52 Week High and Low of Healthcare Global Enterprises Ltd for NSE is ₹ 799.71 and ₹ 513.30 and for BSE is ₹ 799.35 and ₹ 511.83.

What is 1 year return for Healthcare Global Enterprises Ltd?

Answer Field

The 1 year returns on the stock has been 15.76%.

What is the P/E Ratio of Healthcare Global Enterprises Ltd Share?

Answer Field

As on Jun 03 2026 12:46 PM the price-to-earnings (PE) ratio for Healthcare Global Enterprises Ltd share is 644.95.

What is the PB ratio of Healthcare Global Enterprises Ltd Share?

Answer Field

As on Jun 03 2026 12:46 PM, the price-to-book (PB) ratio for Healthcare Global Enterprises Ltd share is 107.48.

How to Buy Healthcare Global Enterprises Ltd Share?

Answer Field

You can trade in Healthcare Global Enterprises Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Healthcare Global Enterprises Ltd Share on Bajaj Broking App?

Answer Field

To buy Healthcare Global Enterprises Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Healthcare Global Enterprises Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|